Azienda Universitaria Ospedaliera Consorziale - Policlinico Bari

InstitutionResearch output, impact & collaborations

Azienda Universitaria Ospedaliera Consorziale - Policlinico Bari is a research organisation in Bari, IT. OpenAlex records 2,432 works and 64,021 citations for it. 753 researchers list it as their most recent affiliation.

2,432

Works

64,021

Citations

753

Researchers

55.1

Avg h-index

IDs:ROR OpenAlex

How has Azienda Universitaria Ospedaliera Consorziale - Policlinico Bari's publication output changed over time?

ScholarIQpublication output · 2002–2024

Output grew0% over the shown period — from 1 works in 2002 to 1 in 2024.

20022009201520172018201920212024

Who are the most-cited researchers behind Azienda Universitaria Ospedaliera Consorziale - Policlinico Bari?

ScholarIQtop researchers by citations

Gennaro Martines · Bariatric Surgery and Outcomes

178 works1,583 citations

Francesco Gaudio · Lymphoma Diagnosis and Treatment

101 works1,191 citations

What are the most-cited papers on Azienda Universitaria Ospedaliera Consorziale - Policlinico Bari?

ScholarIQmost cited works

Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma

Robert J. Motzer, Nizar M. Tannir, Ray McDermott, Osvaldo Arén Frontera, Bohuslav Melichar, Toni K. Choueiri, Elizabeth R. Plimack, Philippe Barthélémy, Camillo Porta, Saby George, Thomas Powles, Frede Donskov, Victoria Neiman, Christian Kollmannsberger, Pamela Salman, Howard Gurney, Robert D. Hawkins, Alain Ravaud, Marc‐Oliver Grimm, Sergio Bracarda, Carlos H. Barrios, Yoshihiko Tomita, Daniel Castellano, Brian I. Rini, Allen C. Chen, Sabeen Mekan, M. Brent McHenry, Megan Wind‐Rotolo, Justin Doan, Padmanee Sharma, Hans J. Hammers, Bernard Escudier

New England Journal of Medicine. 20184,691 CitationsOPEN ACCESS

Lenvatinib plus Pembrolizumab or Everolimus for Advanced Renal Cell Carcinoma

Robert J. Motzer, B. Yа. Alekseev, Sun Young Rha, Camillo Porta, Masatoshi Eto, Thomas Powles, Viktor Grünwald, Thomas E. Hutson, Evgeny Kopyltsov, María José Méndez-Vidal, Vadim Kozlov, Anna Alyasova, Sung‐Hoo Hong, Anil Kapoor, Teresa Alonso Gordoa, Jaime R. Merchan, Eric Winquist, Pablo Maroto, Jeffrey C. Goh, Miso Kim, Howard Gurney, Vijay Patel, Avivit Peer, Giuseppe Procopio, Toshio Takagi, Bohuslav Melichar, Frédéric Rolland, Ugo De Giorgi, Shirley Wong, Jens Bedke, Manuela Schmidinger, Corina E. Dutcus, Alan D. Smith, Lea Dutta, Kalgi Mody, Rodolfo F. Perini, Dongyuan Xing, Toni K. Choueiri

New England Journal of Medicine. 20211,781 CitationsOPEN ACCESS

Nivolumab plus Cabozantinib versus Sunitinib for Advanced Renal-Cell Carcinoma

Toni K. Choueiri, Thomas Powles, Mauricio Burotto, Bernard Escudier, María T. Bourlon, Bogdan Żurawski, Víctor Manuel Oyervides-Juárez, James J. Hsieh, Umberto Basso, Amishi Y. Shah, Cristina Suárez, Alketa Hamzaj, Jeffrey C. Goh, Carlos H. Barrios, Martin Eduardo Richardet, Camillo Porta, Rubén Dario Kowalyszyn, Juan P. Feregrino, Jakub Żołnierek, David Pook, Elizabeth R. Kessler, Yoshihiko Tomita, Ryuichi Mizuno, Jens Bedke, Joshua Zhang, Matthew Maurer, Burçin Şimşek, Flavia Ejzykowicz, Gisela Schwab, Andrea B. Apolo, Robert J. Motzer

New England Journal of Medicine. 20211,773 CitationsOPEN ACCESS

Once-weekly tirzepatide versus once-daily insulin degludec as add-on to metformin with or without SGLT2 inhibitors in patients with type 2 diabetes (SURPASS-3): a randomised, open-label, parallel-group, phase 3 trial

Bernhard Ludvik, Francesco Giorgino, Esteban Jódar, Juan P. Frías, Laura Fernández Landó, Katelyn Brown, Ross Bray, Ángel Rodríguez

The Lancet. 2021621 Citations

Safety and efficacy of sunitinib for metastatic renal-cell carcinoma: an expanded-access trial

Martin Gore, Cezary Szczylik, Camillo Porta, Sergio Bracarda, Georg A. Bjarnason, Stéphane Oudard, Subramanian Hariharan, Se‐Hoon Lee, John B.A.G. Haanen, Daniel Castellano, Eduard Vrdoljak, Patrick Schöffski, Paul N. Mainwaring, Alejandra Nieto, Jinyu Yuan, Ronald M. Bukowski

The Lancet Oncology. 2009591 Citations